146 related articles for article (PubMed ID: 17327443)
1. Endothelin limits insulin action in obese/insulin-resistant humans.
Lteif A; Vaishnava P; Baron AD; Mather KJ
Diabetes; 2007 Mar; 56(3):728-34. PubMed ID: 17327443
[TBL] [Abstract][Full Text] [Related]
2. Hyperinsulinemia fails to augment ET-1 action in the skeletal muscle vascular bed in vivo in humans.
Lteif AA; Fulford AD; Considine RV; Gelfand I; Baron AD; Mather KJ
Am J Physiol Endocrinol Metab; 2008 Dec; 295(6):E1510-7. PubMed ID: 18957616
[TBL] [Abstract][Full Text] [Related]
3. Obesity, type 2 diabetes, and impaired insulin-stimulated blood flow: role of skeletal muscle NO synthase and endothelin-1.
Reynolds LJ; Credeur DP; Manrique C; Padilla J; Fadel PJ; Thyfault JP
J Appl Physiol (1985); 2017 Jan; 122(1):38-47. PubMed ID: 27789766
[TBL] [Abstract][Full Text] [Related]
4. Interactions between endothelin and nitric oxide in the regulation of vascular tone in obesity and diabetes.
Mather KJ; Lteif A; Steinberg HO; Baron AD
Diabetes; 2004 Aug; 53(8):2060-6. PubMed ID: 15277386
[TBL] [Abstract][Full Text] [Related]
5. Endothelin contributes to basal vascular tone and endothelial dysfunction in human obesity and type 2 diabetes.
Mather KJ; Mirzamohammadi B; Lteif A; Steinberg HO; Baron AD
Diabetes; 2002 Dec; 51(12):3517-23. PubMed ID: 12453909
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium-dependent blood flow in obesity.
Laine H; Yki-Jarvinen H; Kirvela O; Tolvanen T; Raitakari M; Solin O; Haaparanta M; Knuuti J; Nuutila P
J Clin Invest; 1998 Mar; 101(5):1156-62. PubMed ID: 9486987
[TBL] [Abstract][Full Text] [Related]
7. Insulin and endothelin in the acute regulation of adiponectin in vivo in humans.
Brame LA; Considine RV; Yamauchi M; Baron AD; Mather KJ
Obes Res; 2005 Mar; 13(3):582-8. PubMed ID: 15833944
[TBL] [Abstract][Full Text] [Related]
8. Dual endothelin receptor blockade acutely improves insulin sensitivity in obese patients with insulin resistance and coronary artery disease.
Ahlborg G; Shemyakin A; Böhm F; Gonon A; Pernow J
Diabetes Care; 2007 Mar; 30(3):591-6. PubMed ID: 17327326
[TBL] [Abstract][Full Text] [Related]
9. Role of endogenous ET-1 in the regulation of myocardial blood flow in lean and obese humans.
Mather KJ; Lteif AA; Veeneman E; Fain R; Giger S; Perry K; Hutchins GD
Obesity (Silver Spring); 2010 Jan; 18(1):63-70. PubMed ID: 19543207
[TBL] [Abstract][Full Text] [Related]
10. Insulin-mediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsiveness in lean humans.
Baron AD; Steinberg HO; Chaker H; Leaming R; Johnson A; Brechtel G
J Clin Invest; 1995 Aug; 96(2):786-92. PubMed ID: 7635973
[TBL] [Abstract][Full Text] [Related]
11. Role of Endothelin-1 Receptors in Limiting Leg Blood Flow and Glucose Uptake During Hyperinsulinemia in Type 2 Diabetes.
Young BE; Padilla J; Finsen SH; Fadel PJ; Mortensen SP
Endocrinology; 2022 Mar; 163(3):. PubMed ID: 35084435
[TBL] [Abstract][Full Text] [Related]
12. A chronic physical activity treatment in obese rats normalizes the contributions of ET-1 and NO to insulin-mediated posterior cerebral artery vasodilation.
Olver TD; McDonald MW; Klakotskaia D; Richardson RA; Jasperse JL; Melling CWJ; Schachtman TR; Yang HT; Emter CA; Laughlin MH
J Appl Physiol (1985); 2017 Apr; 122(4):1040-1050. PubMed ID: 28183819
[TBL] [Abstract][Full Text] [Related]
13. Adipose tissue, hepatic, and skeletal muscle insulin sensitivity in extremely obese subjects with acanthosis nigricans.
Reeds DN; Stuart CA; Perez O; Klein S
Metabolism; 2006 Dec; 55(12):1658-63. PubMed ID: 17142140
[TBL] [Abstract][Full Text] [Related]
14. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance.
Steinberg HO; Chaker H; Leaming R; Johnson A; Brechtel G; Baron AD
J Clin Invest; 1996 Jun; 97(11):2601-10. PubMed ID: 8647954
[TBL] [Abstract][Full Text] [Related]
15. Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone.
Tack CJ; Ong MK; Lutterman JA; Smits P
Diabetologia; 1998 May; 41(5):569-76. PubMed ID: 9628275
[TBL] [Abstract][Full Text] [Related]
16. The interaction of blood flow, insulin, and bradykinin in regulating glucose uptake in lower-body adipose tissue in lean and obese subjects.
Iozzo P; Viljanen A; Guzzardi MA; Laine H; Honka MJ; Ferrannini E; Nuutila P
J Clin Endocrinol Metab; 2012 Jul; 97(7):E1192-6. PubMed ID: 22523335
[TBL] [Abstract][Full Text] [Related]
17. Regulation of glucose uptake by endothelin-1 in human skeletal muscle in vivo and in vitro.
Shemyakin A; Salehzadeh F; Böhm F; Al-Khalili L; Gonon A; Wagner H; Efendic S; Krook A; Pernow J
J Clin Endocrinol Metab; 2010 May; 95(5):2359-66. PubMed ID: 20207830
[TBL] [Abstract][Full Text] [Related]
18. Effects of losartan on whole body, skeletal muscle and vascular insulin responses in obesity/insulin resistance without hypertension.
Lteif AA; Chisholm RL; Gilbert K; Considine RV; Mather KJ
Diabetes Obes Metab; 2012 Mar; 14(3):254-61. PubMed ID: 22051059
[TBL] [Abstract][Full Text] [Related]
19. Insulin resistance in the Zucker diabetic fatty rat: a metabolic characterisation of obese and lean phenotypes.
Leonard BL; Watson RN; Loomes KM; Phillips AR; Cooper GJ
Acta Diabetol; 2005 Dec; 42(4):162-70. PubMed ID: 16382303
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity in insulin-stimulated glucose uptake among different muscle groups in healthy lean people and people with obesity.
Koh HE; van Vliet S; Meyer GA; Laforest R; Gropler RJ; Klein S; Mittendorfer B
Diabetologia; 2021 May; 64(5):1158-1168. PubMed ID: 33511440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
